
Reports of rare clotting and bleeding disorders in younger adults, some fatal, led a number of countries to limit the vaccine’s use to older people, and a few to drop it altogether.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gawB4u
via
IFTTT
0 comments:
Post a Comment